Zvi I. Cabantchik
Jerusalem, JM 91904, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis.
Journal: Journal of neural transmission (Vienna, Austria : 1996)
Published: November 21, 2019
Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?
Journal: Antioxidants & redox signaling
Published: December 31, 2017
Iron as a therapeutic target for Parkinson's disease.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: June 12, 2017
In Search for Symbolic Qualities of Iron: The Metal of Life.
Journal: Frontiers in pharmacology
Published: June 24, 2016
Second international round robin for the quantification of serum non-transferrin-bound iron and labile plasma iron in patients with iron-overload disorders.
Journal: Haematologica
Published: July 23, 2015
The Labile Side of Iron Supplementation in CKD.
Journal: Journal of the American Society of Nephrology : JASN
Published: May 23, 2015
Iron and oxidative stress in cardiomyopathy in thalassemia.
Journal: Free radical biology & medicine
Published: March 10, 2015
A decisional algorithm to start iron chelation in patients with beta thalassemia.
Journal: Haematologica
Published: March 07, 2014
Iron overload and apoptosis of HL-1 cardiomyocytes: effects of calcium channel blockade.
Journal: PloS one
Published: February 23, 2014
Labile iron in cells and body fluids: physiology, pathology, and pharmacology.
Journal: Frontiers in pharmacology
Published: January 12, 2014
Targeting chelatable iron as a therapeutic modality in Parkinson's disease.
Journal: Antioxidants & redox signaling
Published: November 21, 2013
Regional siderosis: a new challenge for iron chelation therapy.
Journal: Frontiers in pharmacology
Published: November 21, 2013
Last Updated: 09/26/2026